Increased expression of an AMPK-related gene, PRKAA1, showed evidence of an effect on reducing Alzheimer’s disease risk (OR 0.95, p=2.36×10−3), slightly under the Bonferroni-corrected threshold. This evidence concerns the gene PRKAA1 and Alzheimer disease.